Home › Trial NCT02627677
A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia
- Trial IDNCT02627677
- StatusTerminated
- PhasePhase 3
- Study typeInterventional
- SponsorAriad Pharmaceuticals
- Enrollment44
- Start date2015-12-31
- ConditionsChronic Phase Chronic Myeloid Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.